- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02299219
Teens Taking Charge: Managing Cancer Online
7. oktober 2019 oppdatert av: Jennifer Stinson, The Hospital for Sick Children
Teens Taking Charge: A Pilot Randomized Controlled Trial of an Online Self-Management and Transitional Care Program for Youth With Cancer
Cancer is the most common potentially fatal disease of adolescence and the Internet represents an ideal means to deliver education, self-monitoring capabilities, and social support to enhance disease self-management by adolescents with cancer.
While two interactive coping websites exist for young people with cancer, they are: (1) not interactive, (2) do not focus on helping youth gain skills for transition and independence, and (3) do not provide opportunities for meaningful social support.
In summary, there is a crucial need to develop a comprehensive interactive Internet-based self-management program targeting AWC that is comprised of cancer education, self-management skills, and opportunities for social support, and that is cost-effective.
Studieoversikt
Status
Fullført
Forhold
Detaljert beskrivelse
Overall aim of this program of research is to develop and evaluate the "Teens Taking Charge: Managing Cancer Online" Internet intervention that will help AWC to better cope with their disease, improve their HRQL, and enhance readiness to transition to adult health care using a sequential phased approach.
The first phase of this project has determined the self-management and transitional care needs of adolescents with cancer.
The second phase consisted of website development and usability testing to ensure the website is easy to use and understand, and is efficient and satisfying to complete.
Subsequently, we will assess the feasibility of the program and the outcomes from the use of the site in a randomized controlled trial (RCT) pilot study (Phase 3).
This will inform the design and methods of the main trial, and will permit us to obtain estimates of treatment effects on AWC health outcomes to inform the calculation of an appropriate sample size for the future definitive RCT (Phase 4).
The focus of this study is Phase 3. Phase 4 will be a multicentre randomized controlled trial to assess outcomes for teens that complete the intervention as compared to those of an attention control group.
Studietype
Intervensjonell
Registrering (Faktiske)
73
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Ontario
-
Hamilton, Ontario, Canada, L8S 4K1
- McMaster Children's Hospital
-
Ottawa, Ontario, Canada, K1H 8L1
- Children's Hospital Eastern Ontario
-
-
Quebec
-
Montreal, Quebec, Canada, H3T 1C5
- CHU Sainte-Justine
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
12 år til 18 år (Barn, Voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
Parents and adolescents will be eligible to participate if the adolescents are:
- between 12-18 years of age
- diagnosed with cancer (at least 3 months from diagnosis)
- on active treatment
- able to speak and read English and/or French at a Grade 6 level
Exclusion Criteria:
Adolescents will be excluded if they:
- have major cognitive impairments
- have reduced executive function that may impact their ability to understand and use the online program
- are terminal/palliative as determined by their oncologist Parents/caregivers are not eligible to participate in the study alone (without an adolescent)
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Aktiv komparator: Kontrollgruppe
|
The control group is designed to control for the potential effects on outcomes of time, attention and computer use during the intervention.
In addition to standard medical care, adolescents in the attention control group will be provided with access to a self-guided patient education study website, which will have two components: basic patient educational materials about Cancer ("Cancer Resource Centre") and online assessments.
|
Eksperimentell: Ta ansvar for eksperimentell gruppe
|
n addition to standard medical care, adolescents in the experimental group will receive the "Taking Charge: Managing Cancer Online" Internet self-management program.
The intervention is a 12-module interactive multi-component treatment protocol that consists of Cancer-specific education, self-management strategies, and social support that is available in English and French.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Participant Accrual and Dropout Rates
Tidsramme: 12 weeks
|
These rates will be centrally tracked by the Clinical Research Project Coordinator
|
12 weeks
|
Fidelity (Any issues or difficulties encountered during implementation of the intervention, control strategy, or outcome measures)
Tidsramme: 12 weeks
|
Any issues or difficulties encountered during implementation of the intervention, control strategy, or outcome measures will be tracked throughout the study by the Clinical Research Project Coordinator
|
12 weeks
|
Acceptability and Satisfaction with Intervention (rate their acceptability of and satisfaction with the intervention)
Tidsramme: 12 weeks
|
Post-treatment, adolescents with cancer and their parents in the intervention group will rate their acceptability of and satisfaction with the intervention
|
12 weeks
|
Engagement with Intervention (Google Analytics will be used to track patterns of website program usage)
Tidsramme: 12 weeks
|
Google Analytics will be used to track patterns of website program usage by adolescents with cancer and their parents
|
12 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Knowledge (Adolescent Cancer Knowledge Questionnaire)
Tidsramme: 12 weeks
|
Measured using the Adolescent Cancer Knowledge Questionnaire, a 15-item tool that assesses cancer-specific knowledge.
|
12 weeks
|
Self-Efficacy (Generalized Self-Efficacy-Sherer Scale)
Tidsramme: 12 weeks
|
Measured by the Generalized Self-Efficacy-Sherer Scale, a 12-item scale that requires adolescents to indicate their level of agreement with a series of statements about self-efficacy.
|
12 weeks
|
Treatment adherence (Medication Adherence Scale)
Tidsramme: 12 weeks
|
Measured with the Medication Adherence Scale, a 4-item scale for assessing self-reported adherence.
|
12 weeks
|
Physical Symptoms - Pain (short form Brief Pain Inventory (BPI)
Tidsramme: 12 weeks
|
Measured using the short form Brief Pain Inventory (BPI), a 15-item measure that includes scales for measuring pain intensity, impact of pain on functioning and well being, and pain interference.
|
12 weeks
|
Physical Symptoms - Fatigue (PedsQL Multidimensional Fatigue Module)
Tidsramme: 12 weeks
|
Measured using the PedsQL Multidimensional Fatigue Module, an 18-item scale with validated versions for child report (ages 8-12 years), teen report (ages 13-18 years), and parental report for children and teens.
|
12 weeks
|
Emotional symptoms (Hospital Anxiety and Depression Scale (HADS)
Tidsramme: 12 weeks
|
Measured using the Hospital Anxiety and Depression Scale (HADS), a 14-item measure for individuals aged >12 years, which can be completed within 2-5 minutes.
|
12 weeks
|
Social functioning (Perceived Social Support from Friends (PSS-Fr) Scale)
Tidsramme: 12 weeks
|
Measured with the Perceived Social Support from Friends (PSS-Fr) Scale, a 20-item scale that assesses the extent to which an individual perceives that their friends fulfill their needs for support.
|
12 weeks
|
Transition readiness (Cancer Transition Scales)
Tidsramme: 12 weeks
|
Measured with the Cancer Transition Scales, which include sub-scales for 'cancer worry' (6 items), 'self-management skills' (15 items), and 'expectations' (12 items).
|
12 weeks
|
Health Related Quality of Life (PedsQL Cancer Module)
Tidsramme: 12 weeks
|
measured with the PedsQL Cancer Module, a 27-item scale, which has validated versions for child, teen, and parental report, and the Health Utility Index [HUI].
|
12 weeks
|
Cost effectiveness (ascertaining direct health care costs and family out of pocket costs)
Tidsramme: 12 weeks
|
Measured by ascertaining direct health care costs and family out of pocket costs related to cancer care incurred over the 12-week study period using the Health Care Utilization form modified from the Ambulatory and Home Care Record84-90 as well as direct costs related to the online intervention technology, intervention training and personnel.
Quality adjusted life years will be calculated using the HUI to determine the incremental cost-effectiveness
|
12 weeks
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Jennifer N Stinson, PhD, CPNP, The Hospital for Sick Children
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
1. januar 2016
Primær fullføring (Faktiske)
1. april 2019
Studiet fullført (Faktiske)
1. april 2019
Datoer for studieregistrering
Først innsendt
17. november 2014
Først innsendt som oppfylte QC-kriteriene
21. november 2014
Først lagt ut (Anslag)
24. november 2014
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
9. oktober 2019
Siste oppdatering sendt inn som oppfylte QC-kriteriene
7. oktober 2019
Sist bekreftet
1. oktober 2019
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- 1000045896
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .